Facetten
Zugriff
Einrichtung
Medientyp
- Text 9
Karte
Erscheinungsjahr
Autor/in
- Schneeweiss, Andreas
- Hartkopf, Andreas D 5
- Müller, Volkmar 5
- Belleville, Erik 4
- Ettl, Johannes 4
- alle zeigen
Sprache
- Englisch 9
9 Einträge gefunden
-
-
-
-
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
HER2-targeted therapy influences CTC status in metastatic breast cancer
- Deutsch, Thomas M
- Riethdorf, Sabine
- Fremd, Carlo
- Feisst, Manuel
- Nees, Juliane
- Fischer, Chiara
- Hartkopf, Andreas D
-
Update Breast Cancer 2020 Part 3 - Early Breast Cancer
- Huober, Jens
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Lux, Michael P
- Janni, Wolfgang
- Ettl, Johannes
-
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- Swain, Sandra M
- Miles, David
- Kim, Sung-Bae
- Im, Young-Hyuck
- Im, Seock-Ah
- Semiglazov, Vladimir
- Ciruelos, Eva
-